You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The test is expected to be available through Asuragen's clinical laboratory improvement amendments-certified lab in the second half of this year.
RNAi- and microRNA-Related Papers Published January 2010
USPTO Publishes Three Patents, Six Patent Applications Related to RNAi
Palle Schelde, Thorlief Moller, John Riis Mortensen, Finn Cilius Nielsen, Ole Bitsch-Jensen, Daniel Kisner, Michael Forrest, Frank Karbe, Kenneth Galbraith, John Chiplin
Using small RNA sequencing, comparative genomics, and other approaches, German and American researchers found close ties between miRNA and tissue evolution in animals with bilateral symmetry.
According to the company, the miRNA is linked to a variety of diseases including cancer, fibrosis, and heart disease.
This month, Weiss presented data suggesting that three microRNAs could be used to identify small-cell lung cancer patients resistant to front-line therapy.
USPTO Publishes Three Patents, Twenty One Patent Applications Related to RNAi
Rosetta plans to use the proceeds for general corporate purposes and to support the development of its microRNA-based diagnostic pipeline.
A German shepherd called Nala has had her genome sequenced.
A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?
Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.
In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.